Fundz

Os Therapies announced it raised $3.5 Million in an initial filing from an offering of $7.53 Million

PUBLIC · OSTXJan 20, 2026

Amount Raised

$3.5 Million

Round Type

Venture

New YorkBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalBiopharma

Company Information

Company

Os Therapies

Location

New York, New York, United States

About

OS Therapies is a clinical stage research company focusing on therapeutic treatments for Osteosarcoma, Breast Cancer and other solid tumors with two platform technologies: OST-HER2 to prevent metastasis and OST-tADC to debulk solid tumors.

Fundz sees it the moment Os Therapies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts hidden hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Os Therapies's next move

See what Strategic adds

Os Therapies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.